Clinical Trials Directory

Trials / Conditions / Invasive Candidiases

Invasive Candidiases

7 registered clinical trials studyying Invasive Candidiases — 2 currently recruiting.

StatusTrialSponsorPhase
CompletedEfficacy of Prophylactic Fluconazole Therapy in Preterm and Very Low Birth Weight Neonates in Preventing Invas
NCT05848492
Services Institute of Medical Sciences, PakistanPhase 3
CompletedAn Open-label Study of APX001 for Treatment of Patients With Candidemia/Invasive Candidiasis Caused by Candida
NCT04148287
Basilea PharmaceuticaPhase 2
RecruitingPosaconazole Pharmacokinetics in Patients Receiving Chemotherapy or Stem Cell Transplants
NCT03717623
Melbourne HealthPhase 4
CompletedStudy of Rezafungin Compared to Caspofungin in Subjects With Candidemia and/or Invasive Candidiasis
NCT03667690
Cidara Therapeutics Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)Phase 3
CompletedInfluence of Open and Laparoscopic Abdominal Surgery Involving the Intestinal Tract on Serum 1,3-ß-D-Glucan (B
NCT03468803
Medical University of GrazN/A
RecruitingECMM Candida Registry - CandiReg
NCT03450005
University of Cologne—
TerminatedA B-D-Glucan Driven Antifungal Stewardship Approach for Invasive Candidiasis
NCT03090334
University of BolognaN/A